-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Scroll Down
People first, Learning centered,
Production oriented
Provide sufficient momentum and innovation gene for building an enterprise exceeding 10 billion.
Focusing on the forefront of research and development of new chemical drugs, SSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
Drug Research Institute of SSY Group Limited covers a total area of over 85 acres, with a construction area of more than 50,000 m2 and a fixed asset investment of more than 500 million RMB, including 200 million RMB of laboratory instruments and equipment. It has HPLC/UPLC, gas chromatograph, Thermo ion chromatograph, Fourier Infrared spectrometer, X-ray diffractometer, Brookraman spectrometer, Malvin particle size meter, ultra-high speed centrifuge, Agilent dissolution apparatus, PE differential scanning calorimeter, Agilent ICP-MS, GC-MS/MS, AB LC-MS/MS, Jena atomic absorption spectrophotometer and other advanced instruments and equipment.
Focus on frontier of medicine
The company gathers international top medical experts, domestic industry senior experts and academic leaders of scientific research institutes. Led by doctors, the scientific research team with all kinds of cutting-edge talents as the backbone focus on the frontier research of medicine.
The high-level professional research teams of synthesis, analysis, preparations and APIs led by doctors and masters have established liquid preparation laboratories, solid preparation laboratories, jointly built laboratories with universities, and pilot laboratories. We have also established high-level innovation platforms such as Engineering Laboratories and Technology Research Centers jointly with Chinese Academy of Sciences, Zhejiang University, Tianjin University and other universities. For now, we have nearly 600 high-level talents in drug research, analysis and clinical research.
First class experimental facilities and beautiful humanistic research environment complement each other
Liquid Chromatography Lab
Active Pharmaceutical Ingredient Laboratory
Gas Chromatography Lab
Every year, we cultivate more than 100 scientific research achievements in the treatment fields of anti-tumor, nervous system and cardiovascular system, as well as a number of national and provincial major scientific and technological innovation and industrialization projects.
Patent Certificate
The products studied mainly involve the treatment fields of respiratory system, neuropsychiatric system, digestive and metabolic system, anti-infection, cardiovascular system, basic infusion (including dialysis and flushing).
Innovative Drug Development Pipeline
It involves tumor, autoimmune disease, organ fibrosis, anesthesia and analgesia, antiviral drugs and other fields. Strategic cooperation with professional teams from China Pharmaceutical University and Shenyang Pharmaceutical University to develop new small molecule drugs, advanced pharmaceutical products and improved new drugs in the fields of cancer, immunity and other diseases.
Generic drugs that have passed the evaluation or are deemed to have passed the evaluation
Generic drug development dosage forms
Lead the future by innovation
SSY Group Limited aims to become one of the “First echelon of pharmaceutical innovation” companies. By continuous strengthening the innovation-driven development, vigorously encouraging the industry and research integration, and unremittingly optimizing the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs, the company promotes the cause of human health with strength from China!
SERVICE HOTLINE
Mobile site
E code
